Why the study?
Does rimiterol compared to isoprenaline have different peripheral and coronary haemodynamic effects?
Does rimiterol compared to isoprenaline have different peripheral and coronary haemodynamic effects?
Rimiterol may be preferable to isoprenaline for treating low-cardiac output syndrome with regional myocardial ischemia, as it avoids direct coronary vasodilation and potential coronary steal.
No takes yet. Share an insight, caveat, or question.
Rimiterol's absent coronary vasodilation merits targeted study in ischemic low-output states; does not yet support clinical preference over isoprenaline.
Stephens et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: